Evigrade
Moderate

Acetylsalicylic acid × diltiazem

Antiplatelet agents (low dose) / NSAIDs (analgesic dose)×Calcium channel blocker, non-DHP (benzothiazepine derivative)

Mechanism

Diltiazem impairs platelet function via calcium channel blockade; aspirin is an antiplatelet. Mild additive bleeding risk, rarely clinically significant.

Symptoms

Usually asymptomatic. In patients with bleeding risk factors (peptic ulcer, older age): rare gum bleeding and epistaxis.

Management

Standard combination in ischaemic heart disease. Cardioprotective aspirin doses (75–100 mg) are acceptable without special measures. In patients with bleeding risk factors: PPI cover with pantoprazole.

Sources

All interactions

Acetylsalicylic acid and diltiazem: interaction, management, sources – Evigrade